Dupuytren's Contracture Genetics

NewsGuard 100/100 Score

Dupuytren's contracture, also known as  Dupuytren's disease, occurs when it is difficult for someone to fully extend their finger because the movement is limited by cords of shortened connective tissue.

Dupuytren's contracture is not a life-threatening condition, and the nodules are not cancerous. However, what happens over time can be discomforting. Eventually, the lumps, or nodules, may grow into cords of cells or tissue. If these strings of tissue have grown along a finger or thumb, they may pull it and bend it toward the center or palm of a hand.

Hand of an man with Dupuytren contracture disease. Image Credit: Fineart1 / Shutterstock
Hand of an man with Dupuytren contracture disease. Image Credit: Fineart1 / Shutterstock

Researchers have not yet been able to determine what causes the condition, but some indicate that the disease may be tied to genetics. Approximately 4 to 7 of every 10 people who have Dupuytren’s also have a family history of the disease.

For many who have the condition, some family members also have the disease. For this reason, some believe that Dupuytren’s is an autosomal dominant disorder that is inherited. The abnormal gene only has to be inherited from one parent for someone to have the disease. That parent also may have the condition. Another reason to believe Dupuytren’s is genetic: It often appears in people of northern European descent.

However, to be clear, there may be other possible causes for this, including:

  • Diabetes, possibly due to high levels of blood sugar;
  • Antiepileptic drugs used to treat epilepsy;
  • Smoking;
  • Excessive use of alcohol.

Yet, many who have Dupuytren’s disease do not have these issues. Some research indicates that any correlations between these conditions and Dupuytren’s are not significant.

Some also believe that previous hand trauma may increase the chance for Dupuytren’s to occur, but such a link to the condition is not clear. Some investigations have indicated that a connection exists between Dupuytren's contracture and manual labor.

Gene Modifications

Some researchers indicate that modifications occurring in certain genes influence the potential for the onset of Dupuytren’s. The Wnt signaling pathway comes into play, affecting some of these genes. The pathway regulates how cells grow and divide. It helps determine a cell’s specific functionality.

An unusual increase in the number of connective tissue cells is key in how Dupuytren’s disease evolves.  The deep fibrous tissue in the hand of those who have this condition has a large number of connective tissue cells which have myofibril protein strands. Myofibrils are the basis of muscle fibers, and help them decrease in size. But the greater number of these fibroblasts in Dupuytren’s facilitates the unusual shortening of fibrous tissue and yields large amounts of type III collagen tissue protein.

The unusual contraction and extra amount of collagen combine to cause the shortening and thickening of fibrous tissue that occurs with Dupuytren’s. Yet, scientists have not been able to make a connection as to how modifications in genes that affect the Wnt signaling pathway may be related to how the condition comes about.

However, other research relates to transforming growth factor beta one (TGF beta 1), a multifunctional cytokine that significantly influences connective tissue and how wounds heal. TGF beta 1 increases the number of fibroblasts and impacts the extracellular matrix. Earlier research established a relationship between TGF beta 1 and Dupuytren’s. It may involve a gene that makes one susceptible to the disease.

Yet some observers think that common TGF beta 1 polymorphisms do not have a link to the onset of Dupuytren’s. But their data may require a cautious interpretation because of the lack of a relationship was established in only one series of patients. More in depth research may paint a different picture and establish a correlation.

Further Reading

Last Updated: Feb 26, 2019

Joseph Constance

Written by

Joseph Constance

Joseph Constance has written about research, development, and markets in the health care and related fields. He has authored a number of articles, and business analysis/market research reports in the medical device, clinical diagnostics, and pharmaceutical areas. Joseph holds an MA from New York University in Communications. He enjoys spending time with his wife, biking, traveling, and learning about different cultures.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Constance, Joseph. (2019, February 26). Dupuytren's Contracture Genetics. News-Medical. Retrieved on May 25, 2024 from https://www.news-medical.net/health/Dupuytrens-Contracture-Genetics.aspx.

  • MLA

    Constance, Joseph. "Dupuytren's Contracture Genetics". News-Medical. 25 May 2024. <https://www.news-medical.net/health/Dupuytrens-Contracture-Genetics.aspx>.

  • Chicago

    Constance, Joseph. "Dupuytren's Contracture Genetics". News-Medical. https://www.news-medical.net/health/Dupuytrens-Contracture-Genetics.aspx. (accessed May 25, 2024).

  • Harvard

    Constance, Joseph. 2019. Dupuytren's Contracture Genetics. News-Medical, viewed 25 May 2024, https://www.news-medical.net/health/Dupuytrens-Contracture-Genetics.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.